https://iets.org.co/nuevo-geovisor-de-vulnerabilidad-de-la-covid-19-en-colombia/ 2022-01-20T14:58:41+00:00 https://iets.org.co:8081/wp-content/uploads/2020/04/Geovisor-DANE-300x188.jpeg https://iets.org.co/iets-anuncia-nuevas-guias-de-practica-clinica-para-el-manejo-de-personas-que-viven-con-vih-en-colombia/ 2022-01-17T15:49:07+00:00 https://iets.org.co/vacunacion-contra-sars-cov-2-en-personas-que-han-tenido-la-infeccion/ 2022-01-17T14:02:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/revision-sistematica-rapida-sobre-el-uso-de-pruebas-diagnosticas-de-tamizaje-como-requisito-para-vuelos-internacionales-en-fase-de-mitigacion/ 2022-01-17T14:02:22+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-seguridad-de-las-plataformas-usadas-en-vacunas-incluyendo-las-de-covid-19/ 2022-01-17T14:02:10+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/revision-rapida-sobre-la-utilidad-del-umbral-de-ciclos-de-la-rt-pcr-en-pacientes-con-sospecha-de-infeccion-por-sars-cov-2/ 2022-01-17T14:01:49+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/protocolo-para-la-evaluacion-rapida-de-la-efectividad-clinica-y-seguridad-del-nusinersen-en-el-tratamiento-de-pacientes-con-atrofia-muscular-espinal-5q/ 2022-01-05T20:39:34+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/tratamiento-de-la-infertilidad-un-protocolo-de-manejo-informado-en-la-evidencia/ 2022-01-05T20:39:17+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-romiplostim-comparado-con-eltrombopag-para-el-tratamiento-de-pacientes-con-purpura-trombocitopenica-inmune-que-fallaron-a-otros-trat/ 2022-01-05T20:39:01+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/protocolo-clinico-para-el-diagnostico-tratamiento-y-ruta-de-atencion-integral-de-ninos-y-ninas-con-trastornos-del-espectro-autista/ 2022-01-05T20:38:43+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/el-analisis-de-costo-efectividad-de-la-radioterapia-el-protocolo-stupp-ps-y-el-ps-mas-bevacizumab-psbev-para-el-tratamiento-de-pacientes-adultos-con-reciente-diagnostico-de-glioblastoma-multifor-2/ 2022-01-05T20:38:27+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-analisis-de-costo-efectividad-de-secukinumab-300mg-vs-ustekinumab-45mg-y-90mg-adalimumab-40-mg-etanercept-50-mg-e-infliximab-5-mg-kg-en-el-tratamiento-de-la-psori/ 2021-10-29T14:12:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-ustekinumab-stelara-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos-4/ 2021-10-28T20:42:41+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-ustekinumab-stelara-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos-3/ 2021-10-28T20:21:51+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-analisis-de-costo-efectividad-de-secukinumab-300mg-vs-ustekinumab-45mg-y-90mg-adalimumab-40-mg-etanercept-50-mg-e-infliximab-5-mg-kg-en-el-tratamiento-de-la-psori-2/ 2021-10-28T15:32:43+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-cost-effectiveness-analysis-of-glycopyrronium-versus-tiotropium-and-fixed-dose-combinations-formoterol-budesonide-and-salmeterol-fluticasone-for-copd-in-the-2/ 2021-10-28T15:14:36+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-costo-efectividad-de-la-combinacion-de-glicopirronio-indacaterol-vs-salmeterol-fluticasona-2/ 2021-10-27T22:37:27+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-secukinumab-cosentyx-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos-2/ 2021-10-27T22:08:12+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-romiplostim-comparado-con-eltrombopag-para-el-tratamiento-de-pacientes-con-purpura-trombocitopenica-inmune-que-fallaron-a-otros-trat-2/ 2021-10-27T21:19:00+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-de-la-evaluacion-economica-de-romiplostim-como-primera-linea-de-tratamiento-en-pacientes-adultos-con-trombocitopenia-inmune-primaria-tip-en-pacientes-esplenectomizados-refractari/ 2021-10-27T19:25:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-prasugrel-para-el-tratamiento-de-pacientes-con-sindrome-coronario-agudo-sca-2/ 2021-10-27T14:26:38+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-efectividad-y-seguridad-de-cefaclor-cefprozil-y-cefuroxima-como-primera-linea-para-neumonia-adquirida-en-la-comunidad-en-menores-de-5-anos/ 2021-10-27T14:04:55+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-pramipexol-para-el-tratamiento-de-la-enfermedad-de-parkinson-de-inicio-temprano/ 2021-10-26T23:09:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-del-stent-medicado-para-pacientes-con-sindrome-coronario-agudo/ 2021-10-26T22:58:15+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-travoprost-para-el-tratamiento-de-glaucoma-de-angulo-abierto-y-cerrado-y-de-la-hipertension-ocular/ 2021-10-26T21:37:59+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-timolol-en-combinaciones-y-dorzolamida-en-combinaciones-para-el-tratamiento-de-glaucoma-de-angulo-abierto-y-cerrado-y-de-la-hipertension-ocular/ 2021-10-26T21:27:48+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-tacrolimus-como-inmunosupresion-primaria-en-receptores-de-trasplante-renal/ 2021-10-26T21:21:34+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-suplementacion-con-zinc-para-el-tratamiento-de-la-enfermedad-diarreica-aguda-en-ninos-y-ninas-menores-5-anos/ 2021-10-26T21:05:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-paroxetina-escitalopram-y-fluvoxamina-como-tratamiento-farmacologico-de-primera-linea-para-depresion-moderada-y-severa-en-poblacion-mayor-de-18-anos/ 2021-10-26T20:58:43+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-de-palivizumab-para-la-reduccion-de-riesgo-de-infeccion-respiratoria-por-virus-sincitial-respiratorio-vsr-en-el-recien-nacido-prematuro/ 2021-10-26T20:10:51+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-efectividad-y-seguridad-del-stent-duodenal-para-el-manejo-de-la-obstruccion-tumoral-del-vaciamiento-gastrico-en-cancer-gastrico-avanzado/ 2021-10-26T19:40:07+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-levofloxacina-y-moxifloxacina-como-monoterapia-ambulatoria-para-neumonia-asociada-a-la-comunidad-en-adultos/ 2021-10-26T16:55:04+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-del-tratamiento-con-hemicolectomia-derecha-por-laparoscopia-para-cancer-colorectal/ 2021-10-26T16:35:42+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-gabapentina-y-pregabalina-como-monoterapia-de-primera-linea-en-adultos-con-dolor-neuropatico/ 2021-10-26T15:58:53+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-quimioterapia-con-el-esquema-mitoxantrone-mas-corticosteroides-para-el-manejo-de-cancer-de-prostata-hormono-refractario/ 2021-10-26T15:42:37+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-terapia-hormonal-con-inhibidores-de-aromatasa-anastrazol-letrozol-exemestane-en-mujeres-postmenopausicas-con-cancer-de-mama-temprano-y-localmente-avanzado-receptor-h/ 2021-10-26T15:33:42+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-fondaparinux-comparado-con-enoxaparina-y-heparina-no-fraccionada-en-pacientes-mayores-de-18-anos-con-sindrome-coronario-agudo-sca/ 2021-10-25T21:39:49+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-efectividad-y-seguridad-de-finasterida-para-el-tratamiento-en-hiperplasia-benigna-de-prostata/ 2021-10-25T21:01:49+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-docetaxel-para-cancer-de-prostata-2/ 2021-10-25T20:06:09+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-carboximetil-celulosa-topica-para-el-tratamiento-sintomatico-del-ojo-seco/ 2021-10-25T19:09:48+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-estramustina-para-el-tratamiento-de-pacientes-con-cancer-de-prostata-avanzado-hormono-refractario/ 2021-10-25T17:16:06+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-fulvestrant-comparado-con-anastrazol-y-exemestane-en-mujeres-posmenopausicas-con-cancer-de-mama-metastasico-o-recurrente-receptor-hormonal-positivo-con-falla-a-la-terapia/ 2021-10-25T17:11:10+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-dexrazoxano-para-prevenir-el-dano-cardiaco-en-pacientes-menores-de-18-anos-con-linfoma-hodgkin-o-leucemia-linfoide-aguda-en-quimioterapia-con-antraciclinas/ 2021-10-25T16:53:57+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-efectividad-y-seguridad-de-deferasirox-en-hemosiderosis-transfusional/ 2021-10-25T16:46:15+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-combinacion-de-brimonidina-con-timolol-para-el-tratamiento-de-glaucoma-de-angulo-abierto-y-cerrado-y-de-la-hipertension-ocular/ 2021-10-25T16:17:36+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-ablacion-por-radiofrecuencia-en-taquicardia-supraventricular/ 2021-10-25T14:49:31+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-oxcarbazepina-lacosamida-vigabatrina-topiramato-y-levetiracetam-como-terapia-adjunta-para-el-tratamiento-de-segunda-linea-en-pacientes-con-epilepsia-refractaria/ 2021-10-25T14:33:28+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/terapia-biologica-para-el-tratamiento-de-pacientes-con-artritis-reumatoide-refractaria-2/ 2021-10-25T14:23:14+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-somatropina-para-el-tratamiento-del-retardo-de-crecimiento-en-ninos-menores-de-18-anos-con-insuficiencia-renal-cronica/ 2021-10-22T22:21:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-cefotaxima-como-primera-linea-para-el-tratamiento-intrahospitalario-de-neumonia-asociada-a-la-comunidad-no-complicada-por-streptococcus-pneumoniae-resistente-en-ninos/ 2021-10-22T21:30:26+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-ranibizumab-comparado-con-terapia-fotodinamica-laser-de-fotocoagulacion-aflibercept-y-bevacizumab-en-pacientes-con-degeneracion-macular-relacionada-con-la-edad/ 2021-10-22T21:13:57+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-oxibutinina-o-tolterodina-comparado-con-darifenacina-solifenacina-fesoterodina-y-placebo-para-el-tratamiento-de-la-incontinencia/ 2021-10-22T21:10:59+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-trimetazidina-en-pacientes-con-angina-estable/ 2021-10-22T21:05:15+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-valganciclovir-comparado-con-ganciclovir-valaciclovir-y-aciclovir-en-pacientes-receptores-de-trasplante-de-organos-solidos/ 2021-10-22T21:00:36+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-del-sorafenib-en-pacientes-con-carcinoma-hepatocelular-avanzado/ 2021-10-22T20:32:33+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-del-adalimumab-para-el-tratamiento-de-personas-con-psoriasis-en-placa-vulgar-moderada-a-severa-o-psoriasis-en-otras-localizaciones/ 2021-10-22T18:06:57+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-seguridad-de-la-vacuna-contra-el-virus-del-papiloma-humano/ 2021-10-22T18:02:54+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-ustekinumab-stelara-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos-2/ 2021-10-22T17:07:21+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-ustekinumab-stelara-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos/ 2021-10-22T16:06:50+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-efectividad-y-seguridad-de-secukinumab-cosentyx-para-el-tratamiento-de-psoriasis-en-placa-moderada-a-severa-en-adultos/ 2021-10-22T15:29:14+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-la-ablacion-con-cateter-por-radiofrecuencia-para-pacientes-con-taquicardia-supraventricular/ 2021-10-20T22:51:01+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-prasugrel-para-el-tratamiento-de-pacientes-con-sindrome-coronario-agudo-sca/ 2021-10-20T22:47:39+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-capecitabina-para-el-manejo-del-cancer-de-mama/ 2021-10-20T22:39:41+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-oxcarbazepina-lacosamida-vigabatrina-topiramato-y-levetiracetam-para-el-tratamiento-de-pacientes-con-epilepsia-refractaria/ 2021-10-20T22:31:32+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-la-carbetocina-durante-el-trabajo-de-parto-en-mujeres-gestantes-en-colombia/ 2021-10-20T22:27:32+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-bicalutamida-para-cancer-de-prostata/ 2021-10-20T22:21:21+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-bevacizumab-en-combinacion-con-quimioterapia-para-el-tratamiento-de-primera-linea-de-cancer-colorrectal/ 2021-10-20T22:16:01+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-adalimumab-infliximab-tocilizumab-abatacept-certolizumab-pegol-golimumab-en-pacientes-con-artritis-reumatoide-refractaria-a-tratamiento-con-farmacos-anti-reuma/ 2021-10-20T22:10:25+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-interferon-s1a-interferon-s1a-recombinante-interferon-s1b-acetato-de-glatiramer-natalizumab-y-fingolimod-para-la-prevencion-de-la-progresion-de-la-discapacidad/ 2021-10-20T20:44:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-metoprolol-para-el-tratamiento-de-pacientes-mayores-de-18-anos-con-sindrome-coronario-agudo-sca/ 2021-10-20T20:40:01+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-fondaparinux-para-el-tratamiento-de-pacientes-mayores-de-18-anos-con-sindrome-coronario-agudo/ 2021-10-20T20:32:44+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-gabapentina-y-pregabalina-como-tratamiento-de-primera-linea-para-adultos-con-dolor-neuropatico/ 2021-10-20T20:29:06+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/manual-para-la-elaboracion-de-evaluaciones-economicas-en-salud/ 2021-10-20T20:26:20+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/manual-para-la-elaboracion-de-evaluaciones-de-efectividad-seguridad-y-validez-diagnostica-de-tecnologias-en-salud/ 2021-10-20T20:23:17+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-fulvestrant-para-el-manejo-del-cancer-de-mama-metastasico/ 2021-10-20T20:20:17+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/manual-para-la-elaboracion-de-analisis-de-impacto-presupuestal-2/ 2021-10-20T20:20:09+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/terapia-biologica-para-el-tratamiento-de-pacientes-con-artritis-reumatoide-refractaria/ 2021-10-20T20:16:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/guia-para-el-involucramiento-de-actores-en-evaluaciones-de-tecnologias-en-salud/ 2021-10-20T20:14:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestario-de-la-cuantificacion-de-la-actividad-enzimatica-para-confirmacion-diagnostica-de-mucopolisacaridosis-tipo-ii-y-iv-a/ 2021-10-20T20:07:29+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/manual-para-la-elaboracion-de-analisis-de-impacto-presupuestal/ 2021-10-20T20:02:06+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-deteccion-de-antigenos-leucocitarios-humanos-hla-15-hla-108-hla-105-hla-109-hla-119-para-el-diagnostico-de-la-enfermedad-de-behcet-2/ 2021-10-20T18:53:43+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-glucocerebrosidasa-en-pacientes-con-sospecha-de-enfermedad-de-gaucher-2/ 2021-10-20T18:37:18+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-del-panel-de-anticuerpos-en-pacientes-con-sospecha-de-dermatomiositis-2/ 2021-10-20T17:32:21+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-condroitin-mas-glucosamina-comparado-con-acetaminofen-aines-y-celecoxib-para-osteoartrosis-sintomatica-primaria-y-secundaria-de-la-rodilla-en-colombia/ 2021-10-20T17:06:27+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-escitalopram-paroxetina-sertralina-fluoxetina-fluvoxamina-y-clomipramina-como-terapia-de-mantenimiento-para-pacientes-adultos-con-trastorno-obsesivo-compulsivo/ 2021-10-20T16:49:16+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-dexmedetomidina-comparado-con-propofol-y-midazolam-para-pacientes-que-requieren-ventilacion-mecanica-y-sedacion-ligera-a-moderada-en-colombia/ 2021-10-20T16:36:42+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-escitalopram-paroxetina-y-venlafaxina-como-terapia-de-mantenimiento-para-pacientes-adultos-con-trastorno-de-fobia-social-en-colombia/ 2021-10-20T16:31:16+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-los-anticuerpos-antipeptidos-ciclicos-citrulinados-anti-ccp-para-el-diagnostico-de-artritis-reumatoide-en-pacientes-mayores-de-16-anos-en-colombia/ 2021-10-20T15:40:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-uso-de-anticuerpos-bloqueadores-de-acetilcolina-receptores-comparado-con-la-prueba-de-tensilon-de-estimulo-repetitivo-electromiografia-con-electrodo-de-fibra-un/ 2021-10-20T14:47:58+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-dabigatran-rivaroxaban-y-apixaban-comparado-con-warfarina-para-prevencion-de-fenomeno-tromboembolico-e-isquemico-en-pacientes-con-fibrilacion-auricular-no-valvular/ 2021-10-20T14:41:58+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-esquema-de-quimioterapia-bortezomib-mas-ciclofosfamida-mas-dexamestasona-versus-la-inclusion-de-este-esquema-en-el-plan-obligatorio-de-salud-como-tratamiento-de-2/ 2021-10-20T14:34:22+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-lenalidomida-mas-terapia-de-soporte-comparada-con-terapia-de-soporte-sin-lenalidomida-para-el-tratamiento-de-pacientes-con-sindrome-mielodisplasico-y-delecion-5q-en/ 2021-10-20T14:19:36+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-escitalopram-paroxetina-y-venlafaxina-como-terapia-de-mantenimiento-para-pacientes-adultos-con-trastorno-de-ansiedad-generalizada-en-colombia/ 2021-10-20T14:14:34+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-everolimus-mas-ciclosporina-y-prednisona-comparado-con-micofenolato-mas-ciclosporina-y-prednisona-para-la-profilaxis-del-rechazo-en-los-receptores-de-trasplante-d-2/ 2021-10-20T14:00:25+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-everolimus-mas-ciclosporina-y-prednisona-comparado-con-micofenolato-mas-ciclosporina-y-prednisona-para-la-profilaxis-del-rechazo-en-los-receptores-de-trasplante-de/ 2021-10-20T13:49:37+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-uso-de-inmunoglobulina-humana-normal-para-los-pacientes-con-deficiencia-inmune-primaria-en-colombia/ 2021-10-19T23:22:39+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-octreotide-lanreotide-para-pacientes-con-acromegalia-en-colombia/ 2021-10-19T22:41:07+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-ranibizumab-comparado-con-aflibercept-triamcinolona-y-bevacizumab-para-tratamiento-de-pacientes-con-edema-macular-secundario-a-oclusion-de-la-vena-central-de-retin/ 2021-10-19T21:46:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-escitalopram-paroxetina-y-fluvoxamina-como-terapia-de-mantenimiento-para-pacientes-adultos-con-trastorno-de-panico-en-colombia/ 2021-10-19T21:26:02+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-pramipexol-comparado-con-levodopa-como-terapia-de-primera-linea-para-pacientes-con-sindrome-de-piernas-inquietas-en-colombia/ 2021-10-19T20:31:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-la-temozolomida-para-el-tratamiento-de-pacientes-adultos-con-diagnostico-de-novo-de-glioma-maligno-en-colombia/ 2021-10-19T20:24:46+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-somatropina-para-el-tratamiento-de-la-restriccion-del-crecimiento-en-ninas-con-sindrome-de-turner-en-colombia/ 2021-10-19T20:18:32+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-ranibizumab-aflibercept-y-bevacizumab-para-tratamiento-de-pacientes-con-degeneracion-macular-relacionada-a-la-edad-en-colombia/ 2021-10-19T19:50:16+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-levofloxacina-y-moxifloxacina-para-el-tratamiento-de-adultos-con-comorbilidades-alergia-o-intolerancia-a-los-betalactamicos-con-neumonia-adquirida-en-comunidad/ 2021-10-19T18:16:59+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-esquema-de-quimioterapia-bortezomib-mas-ciclofosfamida-mas-dexamestasona-versus-la-inclusion-de-este-esquema-en-el-plan-obligatorio-de-salud-como-tratamiento-de-in/ 2021-10-19T17:41:23+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-apixaban-dabigatran-fondaparinux-y-rivaroxaban-en-profilaxis-para-tromboembolismo-venoso-en-pacientes-con-artroplastia-de-rodilla-en-colombia/ 2021-10-19T17:33:49+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-los-procedimientos-quirurgicos-de-ginecologia-via-laparoscopica-versus-su-equivalente-por-via-abierta-en-colombia/ 2021-10-19T17:31:21+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-los-procedimientos-quirurgicos-de-torax-via-laparoscopica-versus-su-equivalente-por-via-abierta-en-colombia/ 2021-10-19T17:28:10+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-los-procedimientos-quirurgicos-de-urologia-via-laparoscopica-versus-su-equivalente-por-via-abierta-en-colombia/ 2021-10-19T17:26:14+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-flavoxato-oxibutinina-tolterodina-solifenacina-darifenacina-y-mirabegron-para-el-tratamiento-de-incontinencia-urinaria-de-urgencia-en-colombia/ 2021-10-19T17:08:23+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-citalopram-clomipramina-escitalopram-paroxetina-fluvoxamina-fluoxetina-y-sertralina-para-pacientes-con-trastorno-obsesivo-compulsivo-en-colombia/ 2021-10-19T17:07:18+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-implante-coclear-para-pacientes-con-hipoacusia-neurosensorial-profunda-bilateral-en-colombia/ 2021-10-19T17:05:59+00:00 https://iets.org.co/analisis-de-impacto-presupuestal-de-medicamentos-para-el-tratamiento-preventivo-de-migrana-en-colombia/ 2021-10-19T17:00:45+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-la-radioterapia-para-el-tratamiento-de-los-carcinomas-ubicados-en-la-region-anatomica-de-cabeza-y-cuello-en-colombia/ 2021-10-19T16:54:05+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-los-procedimientos-quirurgicos-de-abdomen-via-laparoscopica-versus-su-equivalente-por-via-abierta-en-colombia/ 2021-10-19T16:39:14+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-beclometasona-budesonida-ciclesonida-deflazacort-fluticasona-propionato-formoterol-formoterol-budesonida-ipratropio-bromuro-metilprednisolona-mometason-2/ 2021-10-19T16:17:22+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-medicamentos-para-el-tratamiento-del-episodio-agudo-de-migrana-en-colombia/ 2021-10-19T15:53:53+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-de-tecnologias-para-el-manejo-complementario-de-quimioterapia-en-colombia/ 2021-10-19T15:48:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-stent-medicado-para-pacientes-con-sindrome-coronario-agudo-que-requieren-intervencion-coronaria-percutanea-con-colocacion-de-stent-en-colombia/ 2021-10-19T14:36:49+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-impacto-presupuestal-del-kit-de-ostomia-para-pacientes-con-ostomias-enterales-o-urinarias-en-colombia/ 2021-10-19T14:31:28+00:00 https://iets.org.co/guia-de-practica-clinica-gpc-para-el-diagnostico-tratamiento-y-rehabilitacion-del-episodio-agudo-del-ataque-cerebrovascular-lsquemico-en-poblacion-mayor-de-18-anos/ 2021-10-14T15:42:29+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-la-inmunofluorescencia-directa-para-el-diagnostico-de-la-dermatitis-herpetiforme/ 2021-10-01T14:38:28+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-tomografia-por-emision-de-positrones-la-tomografia-por-emision-de-foton-unico-y-la-resonancia-de-alto-campo-para-la-localizacion-del-foco-epileptogeno-en-pacientes-candidato/ 2021-10-01T14:37:44+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-del-panel-de-anticuerpos-en-pacientes-con-sospecha-de-dermatomiositis/ 2021-10-01T14:37:34+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-glucocerebrosidasa-en-pacientes-con-sospecha-de-enfermedad-de-gaucher/ 2021-10-01T14:37:22+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-deteccion-de-antigenos-leucocitarios-humanos-hla-15-hla-108-hla-105-hla-109-hla-119-para-el-diagnostico-de-la-enfermedad-de-behcet/ 2021-10-01T14:37:09+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-ph-metria-para-la-confirmacion-del-diagnostico-de-reflujo-gastroesofagico/ 2021-08-30T16:01:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-manometria-esofagica-como-prueba-diagnostica-para-los-trastornos-de-motilidad-esofagica/ 2021-08-30T15:56:51+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-las-pruebas-geneticas-brca1-y-brca2/ 2021-08-30T15:51:43+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-ph-metria-para-la-confirmacion-del-reflujo-gastroesofagico/ 2021-08-30T15:45:55+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-y-utilidad-diagnostica-del-fototest-para-el-diagnostico-de-urticaria-solar/ 2021-08-30T14:54:10+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-la-medicion-volumenes-pulmonares-por-pletismografia-para-el-apoyo-complementario-del-diagnostico-y-seguimiento-de-fibrosis-pulmonar-idiopatica/ 2021-08-30T14:48:44+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/validez-diagnostica-de-los-anticuerpos-de-los-peptidos-anticiclicos-citrulinados-ac-anti-ccp-para-artritis-psoriasica/ 2021-08-30T14:34:53+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-la-deteccion-de-anticuerpos-anti-acuaporina-4-para-el-diagnostico-de-neuromielitis-optica/ 2021-08-30T14:27:47+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/via-clinica-para-el-tratamiento-de-hepatitis-c-cronica/ 2021-08-30T13:59:44+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/guidelines-for-the-economic-evaluation-of-healthcare-technologies-in-colombia-technical-support-documents/ 2021-08-24T20:17:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/opciones-en-colombia-para-la-regulacion-del-uso-de-sistemas-electronicos-con-o-sin-dispensacion-de-nicotina-un-resumen-de-evidencias-para-politica-policy-brief/ 2021-08-24T20:12:50+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/guia-practica-clinica-2/ 2021-08-24T16:41:42+00:00 https://iets.org.co/aniversario-del-iets/ 2021-08-24T16:37:43+00:00 https://iets.org.co/guia-practica-clinica/ 2021-08-24T16:36:35+00:00 https://iets.org.co/iets-apoyara-el-acuerdo-entre-colombia-y-corea-para-la-atencion-a-la-emergencia-de-covid-19/ 2021-08-24T16:20:27+00:00 https://iets.org.co/analisis-de-costo-efectividad-del-uso-del-desfibrilador-externo-automatico-dea-comparado-con-reanimacion-cardiopulmonar-basica-rcp-en-colombia/ 2021-08-06T02:25:13+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-escitalopram-comparado-con-paroxetina-sertralina-fluoxetina-y-venlafaxina-como-terapia-de-mantenimiento-para-pacientes-con-trastorno-de-fobia-social-en-colombia/ 2021-08-06T02:21:18+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-lenalidomida-mas-terapia-de-soporte-comparada-con-terapia-de-soporte-sin-lenalidomida-para-el-tratamiento-de-pacientes-con-sindrome-mielodisplasico-y-delecion-5q-en-co/ 2021-08-06T02:18:27+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-del-condroitin-mas-glucosamina-comparado-con-acetaminofen-aines-y-celecoxib-para-el-tratamiento-sintomatico-de-adultos-con-osteoartrosis-de-rodilla-y-mano-en-colombia/ 2021-08-06T02:15:22+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-del-clorhidrato-de-dexmedetomidina-comparada-con-propofol-y-midazolam-para-la-sedacion-ligera-a-moderada-de-adultos-con-ventilacion-mecanica-invasiva-en-unidades-de-cuida/ 2021-08-06T02:13:32+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/el-analisis-de-costo-efectividad-de-la-radioterapia-el-protocolo-stupp-ps-y-el-ps-mas-bevacizumab-psbev-para-el-tratamiento-de-pacientes-adultos-con-reciente-diagnostico-de-glioblastoma-multifor/ 2021-08-06T02:04:55+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-escitalopram-comparado-con-paroxetina-fluoxetina-sertralina-fluvoxamina-y-clomipramina-como-terapia-de-mantenimiento-para-pacientes-con-trastorno-obsesivo-compulsiv/ 2021-08-06T02:03:05+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-escitalopram-comparado-con-paroxetina-sertralina-y-venlafaxina-como-terapia-de-mantenimiento-para-pacientes-con-trastorno-de-ansiedad-generalizada-en-colombia/ 2021-08-06T01:49:52+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-everolimus-mas-ciclosporina-y-prednisona-comparado-con-micofenolato-mas-ciclosporina-y-prednisona-para-la-inmunosupresion-de-mantenimiento-en-el-trasplante-renal-en-co/ 2021-08-06T01:48:42+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-everolimus-mas-tacrolimus-y-prednisolona-comparado-con-tacrolimus-mas-prednisolona-para-la-inmunosupresion-de-mantenimiento-en-el-trasplante-hepatico-en-colombia/ 2021-08-06T01:41:25+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-everolimus-mas-ciclosporina-y-prednisona-comparado-con-micofenolato-mas-ciclosporina-y-prednisona-para-la-inmunosupresion-de-mantenimiento-en-el-trasplante-cardiaco-en/ 2021-08-06T01:36:36+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-lanreotide-octreotide-y-cabergolina-para-el-tratamiento-de-pacientes-con-acromegalia-en-colombia/ 2021-08-06T01:35:57+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-ranibizumab-comparado-con-implante-intravitreo-de-dexametasona-triamcinolona-aflibercept-y-bevacizumab-para-pacientes-el-tratamiento-de-pacientes-con-edema-macular-2/ 2021-08-06T01:27:33+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-ranibizumab-comparado-con-aflibercept-y-bevacizumab-para-el-tratamiento-de-pacientes-con-degeneracion-macular-relacionada-con-la-edad-dmre-de-tipo-neovascular-en-col/ 2021-08-06T01:26:42+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-pramipexol-comparado-con-levodopa-y-cabergolina-para-pacientes-con-sindrome-de-piernas-inquietas-en-colombia/ 2021-08-06T01:19:41+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/analisis-de-costo-efectividad-de-ranibizumab-comparado-con-implante-intravitreo-de-dexametasona-triamcinolona-aflibercept-y-bevacizumab-para-pacientes-el-tratamiento-de-pacientes-con-edema-macular/ 2021-08-06T01:15:32+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-cost-effectiveness-analysis-of-glycopyrronium-versus-tiotropium-and-fixed-dose-combinations-formoterol-budesonide-and-salmeterol-fluticasone-for-copd-in-the/ 2021-08-06T01:07:40+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/apreciacion-critica-del-estudio-costo-efectividad-de-la-combinacion-de-glicopirronio-indacaterol-vs-salmeterol-fluticasona/ 2021-08-06T01:04:24+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/documentos-tecnicos-de-apoyo-a-la-construccion-del-caso-de-referencia-colombiano-para-la-evaluacion-economica-en-salud/ 2021-08-05T23:20:30+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-seguridad-y-analisis-economico-de-la-tomografia-por-emision-de-positrones-para-el-diagnostico-en-epilepsia/ 2021-08-05T02:57:16+00:00 https://iets.org.co/efectividad-y-seguridad-de-la-prostatectomia-por-laparoscopia-para-el-tratamiento-del-cancer-de-prostata-localizado/ 2021-08-05T02:46:08+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-la-radioterapia-conformacional-en-cancer-gastrico/ 2021-08-05T02:41:51+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/evaluacion-de-efectividad-y-seguridad-de-riluzol-como-tratamiento-para-prolongar-el-tiempo-libre-de-traqueostomia-en-pacientes-con-esclerosis-lateral/ 2021-08-05T02:37:41+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-risperidona-en-terapia-combinada-con-estabilizadores-del-animo-en-personas-con-trastorno-afectivo-bipolar/ 2021-08-05T02:32:54+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-somatostatina-comparada-con-octreotida-y-terlipresina-para-el-control-de-la-hemorragia-de-vias-digestivas-altas-en-adultos-con-varices-esofagicas/ 2021-08-05T02:27:48+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-de-dorzolamida-para-el-tratamiento-de-glaucoma-de-angulo-abierto-y-cerrado-y-de-la-hipertension-ocular/ 2021-08-05T02:23:51+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co/efectividad-y-seguridad-del-interferon-s1a-recombinante-interferon-s1b-acetato-de-glatiramer-natalizumab-y-fingolimod-para-la-prevencion-de-la-progresion-de-la-discapacidad-en-adultos-con-esclerosi/ 2021-08-05T02:07:47+00:00 https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png https://iets.org.co:8081/wp-content/uploads/2021/08/download-IETS.png